Literature DB >> 11960907

Malignant conversion of non-tumorigenic murine skin keratinocytes overexpressing PACE4.

Haleh Mahloogi1, Daniel E Bassi, Andres J P Klein-Szanto.   

Abstract

Proprotein convertases (PCs) have been implicated in tumor cell invasion by processing a variety of substrates including matrix metalloproteinases (MMPs). PACE4, a member of the family of PCs was shown to enhance mouse skin carcinoma progression by increasing tumor cell invasiveness. However, the effects of PACE4 on malignant conversion have not been investigated. In the present study we address the possible role of PACE4 as a trigger of malignant conversion by transfecting with a full-length PACE4 cDNA, three keratinocyte cell lines with no or little tumorigenic potential, i.e. non-tumorigenic BALB/MK-2 cells, tumorigenic non-invasive MT1/2 cells and tumorigenic moderately invasive p117 mouse skin keratinocytes. Overexpression of PACE4 led to a significant increase in the processing of stromelysin-3, a well-characterized substrate of this PC. When assayed for invasive ability, the PACE4-transfected cells were invasive both in vitro and in vivo, whereas their control counterparts were not. In addition, an enhanced processing ability of MT2-MMP a known substrate of PCs was detected in the PACE4-transfected cells. This was accompanied by MMP-2 and MMP-9 activation in PACE4 transfectants. Invasion and MMP processing were remarkably reduced when PACE4 was inhibited with a specific antibody. By triggering the processing of crucial invasion-related proteases, PACE4 is not only able to enhance the invasive ability of malignant cells as demonstrated previously, but also played a significant role in converting non-invasive keratinocytes into malignant cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11960907     DOI: 10.1093/carcin/23.4.565

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  17 in total

Review 1.  Furin at the cutting edge: from protein traffic to embryogenesis and disease.

Authors:  Gary Thomas
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

2.  On the cutting edge of proprotein convertase pharmacology: from molecular concepts to clinical applications.

Authors:  Frédéric Couture; François D'Anjou; Robert Day
Journal:  Biomol Concepts       Date:  2011-10-01

3.  Enhanced aggressiveness of benzopyrene-induced squamous carcinomas in transgenic mice overexpressing the proprotein convertase PACE4 (PCSK6).

Authors:  Daniel E Bassi; Jonathan Cenna; Jirong Zhang; Edna Cukierman; Andres J Klein-Szanto
Journal:  Mol Carcinog       Date:  2014-05-21       Impact factor: 4.784

4.  Germline DNA copy number variations as potential prognostic markers for non-muscle invasive bladder cancer progression.

Authors:  Yoshiaki Yamamoto; Yutaka Suehiro; Atomu Suzuki; Ryosuke Nawata; Yoshihisa Kawai; Ryo Inoue; Hiroshi Hirata; Hiroaki Matsumoto; Takahiro Yamasaki; Kohsuke Sasaki; Hideyasu Matsuyama
Journal:  Oncol Lett       Date:  2017-05-24       Impact factor: 2.967

5.  Expression of paired basic amino acid-cleaving enzyme 4 (PACE4) correlated with prognosis in non-small cell lung cancer (NSCLC) patients.

Authors:  Yun-En Lin; Qi-Nian Wu; Xiao-Dong Lin; Guang-Qiu Li; Ya-Jie Zhang
Journal:  J Thorac Dis       Date:  2015-05       Impact factor: 2.895

6.  Proprotein convertase inhibition results in decreased skin cell proliferation, tumorigenesis, and metastasis.

Authors:  Daniel E Bassi; Jirong Zhang; Jonathan Cenna; Samuel Litwin; Edna Cukierman; Andres J P Klein-Szanto
Journal:  Neoplasia       Date:  2010-07       Impact factor: 5.715

7.  Regulation of HIF-1 alpha by the proprotein convertases furin and PC7 in human squamous carcinoma cells.

Authors:  Jian Fu; Jirong Zhang; Yulan Gong; Courtney Lyons Testa; Andres J Klein-Szanto
Journal:  Mol Carcinog       Date:  2014-01-16       Impact factor: 4.784

8.  Role of proprotein convertases in prostate cancer progression.

Authors:  Frédéric Couture; François D'Anjou; Roxane Desjardins; François Boudreau; Robert Day
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

Review 9.  Role of subtilisin-like convertases in cadherin processing or the conundrum to stall cadherin function by convertase inhibitors in cancer therapy.

Authors:  E J Müller; R Caldelari; H Posthaus
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

10.  Enhanced UV-induced skin carcinogenesis in transgenic mice overexpressing proprotein convertases.

Authors:  Jian Fu; Daniel E Bassi; Jirong Zhang; Tianyu Li; Kathy Q Cai; Courtney Lyons Testa; Emmanuelle Nicolas; Andres J Klein-Szanto
Journal:  Neoplasia       Date:  2013-02       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.